Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sionna Therapeutics, Inc. - Common Stock
(NQ:
SION
)
36.34
-2.91 (-7.41%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Sionna Therapeutics, Inc. - Common Stock
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Participate in Upcoming December Investor Conferences
November 24, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Reports Third Quarter 2025 Financial Results
November 05, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Participate in Upcoming November Investor Conferences
November 04, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
October 24, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis
October 21, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
October 01, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer
September 08, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Reports Second Quarter 2025 Financial Results
August 11, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model
June 06, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis
June 04, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis Conference
May 22, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Reports First Quarter 2025 Financial Results
May 12, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025
April 30, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
March 20, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference
February 24, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 10, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
